Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
regulatory
Manufacturing
Compounder in Lilly lawsuit hit with FDA warning letter
A compounding pharmacy recently roped into Lilly’s fight against knockoff GLP-1s has landed in the FDA’s crosshairs for the second time in a year.
Fraiser Kansteiner
Apr 24, 2025 8:20am
FDA asks Novavax for data pledge amid stalled COVID shot review
Apr 23, 2025 9:17am
FDA staff cuts threaten upcoming user fee renewal talks: Reuters
Apr 18, 2025 11:10am
Ex-CBER chief says FDA layoffs threaten future drug reviews: BMO
Apr 17, 2025 2:55pm
Senate confirms surgeon Marty Makary as new FDA commissioner
Mar 26, 2025 10:43am
Merck preps filings after Winrevair succeeds in severe PAH study
Nov 25, 2024 9:00am
